| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/29/2007 | US20070069416 Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
| 03/29/2007 | US20070068959 Preparing for individualized dosage forms of medicaments |
| 03/29/2007 | DE60119337T2 Aseptische mittel Aseptic medium |
| 03/29/2007 | DE10330971B4 Verfahren zur Herstellung von Haut- oder Wundauflagen mit verkapselten, wundheilungsfördernden und/oder hautpflegenden Substanzen Process for the preparation of skin or wound dressings containing encapsulated, wound healing and / or skin care substances |
| 03/29/2007 | DE10300187B4 Kaugummizusammensetzung mit pflanzlichen Wirkstoffen The chewing gum composition with herbal ingredients |
| 03/29/2007 | DE10207394B4 Geschmacksmaskierte oblatenförmige Arzneizubereitung A taste masked pharmaceutical preparation wafer-shaped |
| 03/29/2007 | DE102005047691A1 Multiple-coated nano-particle, useful for transporting an active substance to a target cell, comprises an inner core, an inner sheath surrounding the core and an outer sheath surrounding the core and inner sheath |
| 03/29/2007 | DE102005045989A1 Powder base, useful for e.g. protecting the skin from disorders, comprises e.g. protective material, mineral pigment, different organic materials, urea, antimicrobial-, antiseptic-, anitinflammatory- and itch protective- agents |
| 03/29/2007 | CA2713219A1 Oral vehicle for systemic pharmaceuticals |
| 03/29/2007 | CA2623281A1 Composition comprising a nsaid and paracetamol |
| 03/29/2007 | CA2622997A1 A liposome composition to cause lysis of cells and pathogens |
| 03/29/2007 | CA2622869A1 Modifying leukocyte function |
| 03/29/2007 | CA2622758A1 Nanoparticulate aripiprazole formulations |
| 03/29/2007 | CA2622704A1 Highly concentrated pourable aqueous solutions of potassium ibuprofen their preparation and their uses |
| 03/29/2007 | CA2622693A1 Sachet formulation for amine polymers |
| 03/29/2007 | CA2621899A1 Aryl/alkyl succinic anhydride hyaluronan derivatives |
| 03/29/2007 | CA2561603A1 Dental device with improved retention of a flavor and/or chemotherapeutic agent composition |
| 03/28/2007 | EP1767632A2 A method for local administration of synthetic double-stranded oligonucleotides targeting a VEGF receptor |
| 03/28/2007 | EP1767575A1 Gel-form water-absorbing material |
| 03/28/2007 | EP1767536A1 Quinolone carboxylic acid derivatives, thereof preparation and usage |
| 03/28/2007 | EP1767220A1 Eriodictyon extract containing pharmaceuticals for nasal administration |
| 03/28/2007 | EP1767219A2 Stable injectable diclofenac compositions |
| 03/28/2007 | EP1767218A1 Antiinflammatory and analgesic preparation for external use |
| 03/28/2007 | EP1767216A1 Drug having regulatory cell ligand contained in liposome |
| 03/28/2007 | EP1767207A2 Solid Oral Dosage Forms |
| 03/28/2007 | EP1767206A2 Solid Oral Dosage Forms |
| 03/28/2007 | EP1767196A2 Highly efficient delivery of a large therapeutic mass aerosol |
| 03/28/2007 | EP1767195A2 Stable spray-dried protein formulations |
| 03/28/2007 | EP1767194A1 Process for the preparation of adsorbates of drospirenone |
| 03/28/2007 | EP1767193A2 Pharmaceutical compositions |
| 03/28/2007 | EP1767192A2 Cationic lipid compositions targeting angiogenic endothelial cells |
| 03/28/2007 | EP1767175A1 Controlled release system for delivering therapeutic agents into the inner ear |
| 03/28/2007 | EP1766591A1 Communication unit for a person's skin |
| 03/28/2007 | EP1766564A2 System and method for automatic generation of a hierarchical tree network and the use of two complementary learning algorithms, optimized for each leaf of the hierarchical tree network |
| 03/28/2007 | EP1766035A1 Lipid encapsulated interfering rna |
| 03/28/2007 | EP1766009A2 Treatment of neurodegenerative disease through intracranial delivery of sirna |
| 03/28/2007 | EP1765894A1 Novel temperature and ph sensitive copolymers |
| 03/28/2007 | EP1765875A1 Polymer films |
| 03/28/2007 | EP1765455A2 Devices and methods for measuring and enhancing drug or analyte transport to/from medical implant |
| 03/28/2007 | EP1765452A1 Delivery system |
| 03/28/2007 | EP1765417A2 Immunostimulatory oligonucleotide multimers |
| 03/28/2007 | EP1765407A1 Binary thermo-gelling composition |
| 03/28/2007 | EP1765382A1 Intranasal formulations of interferon beta free of stabilizers that are proteins or polypeptides |
| 03/28/2007 | EP1765380A1 Method of treating parkinson"s disease in humans by direct infusion of glial cell-line derived neurotrophic factor into the zona incerta |
| 03/28/2007 | EP1765376A1 Topical compositions and methods for epithelial-related conditions |
| 03/28/2007 | EP1765373A2 Ozonidzed pharmaceutical composition and method |
| 03/28/2007 | EP1765369A2 Process for the preparation of calcium phosphate granules of the hydroxyapatite type |
| 03/28/2007 | EP1765367A1 Phospholipid compositions and methods for their preparation and use |
| 03/28/2007 | EP1765356A1 Spray composition comprising a combination of calcitriol and clobetasol propionate, an alcoholic phase, at least one volatile silicone and one non volatile oily phase |
| 03/28/2007 | EP1765353A1 Solid orally ingestible formulations of tetrodotoxin |
| 03/28/2007 | EP1765350A1 Manufacturing method of solid dispersion containing itraconazole |
| 03/28/2007 | EP1765340A1 Sustained release composition for oral administration of niacin |
| 03/28/2007 | EP1765310A2 A mixture for transdermal delivery of low and high molecular weight compounds |
| 03/28/2007 | EP1765309A1 Smokeless toabacco product |
| 03/28/2007 | EP1765308A2 Anti-microbial dental formulations for the prevention and treatment of oral mucosal disease |
| 03/28/2007 | EP1765307A1 Dry-coating process |
| 03/28/2007 | EP1765306A2 Capsule for releasing agents contained therein at defined points in a body |
| 03/28/2007 | EP1765305A1 Controlled phase composition technology as an improved process for protection of drugs |
| 03/28/2007 | EP1765304A1 Compressed chewing gum tablet |
| 03/28/2007 | EP1765303A1 Oral dosage form safeguarded against abuse |
| 03/28/2007 | EP1765302A2 Optically controlled microfluidic chip |
| 03/28/2007 | EP1765300A2 Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same |
| 03/28/2007 | EP1765299A1 Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight |
| 03/28/2007 | EP1765298A1 Method for producing a solid dosage form, which is safeguarded against abuse, while using a planetary gear extruder |
| 03/28/2007 | EP1765297A2 Porous tablets as carriers for liquid formulations |
| 03/28/2007 | EP1765296A2 High ibuprofen content granules and their preparation and use |
| 03/28/2007 | EP1765295A1 Sustained-release composition, process for producing the same and use of the same |
| 03/28/2007 | EP1765294A1 Nucleic acid microspheres, production and delivery thereof |
| 03/28/2007 | EP1765293A2 Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same |
| 03/28/2007 | EP1765292A1 Abuse-deterrent drug formulations |
| 03/28/2007 | EP1765291A1 Enhanced medical product |
| 03/28/2007 | EP1765290A2 Stabilised supersaturated solid solutions of steroidal drugs |
| 03/28/2007 | EP1765289A2 Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids |
| 03/28/2007 | EP1765288A1 Methods of treatment of endobronchial infections |
| 03/28/2007 | EP1765287A2 Immediate release formulations of memantine oral dosage forms |
| 03/28/2007 | EP1765286A2 Pharmaceutically elegant, topical anhydrous aerosol foam |
| 03/28/2007 | EP1765285A2 Poly (lactid acid) copolymer hydrogels and related methods of drug delivery |
| 03/28/2007 | EP1765284A1 Retinoid-containing sustained release intraocular drug delivery systems and related methods of manufacturing |
| 03/28/2007 | EP1765283A2 Pharmaceutical compositions |
| 03/28/2007 | EP1765089A2 Compositions comprising edible oils and vitamins and/or minerals and methods for making the compositions |
| 03/28/2007 | EP1765071A2 A safe delivery system for agriculturally active materials |
| 03/28/2007 | EP1587609B1 Emulsions including surface-modified organic molecules |
| 03/28/2007 | EP1513555B1 Formulations of quinapril and related ace inhibitors |
| 03/28/2007 | EP1499312B1 The use of hydroxypyridone-derivatives in wound healing |
| 03/28/2007 | EP1448710B1 Ph responsive biodegradable polylactic acid derivatives forming polymeric micelles and uses thereof for poorly water soluble drug delivery |
| 03/28/2007 | EP1423175A4 Methods for micronization of hydrophobic drugs |
| 03/28/2007 | EP1414470B1 Micronutrient phosphates as dietary and health supplements |
| 03/28/2007 | EP1331933B1 Tiagabine for the treatment of diabetic neuropathy |
| 03/28/2007 | EP1292381A4 Process and device for producing liquid dosage formulations |
| 03/28/2007 | EP1292298B1 Intracorporeal medicaments for high energy phototherapeutic treatment of disease |
| 03/28/2007 | EP1254944B1 Dry compositions containing hydrophobic amino acid |
| 03/28/2007 | EP1233761B1 Osmotic dosage form comprising first and second coats |
| 03/28/2007 | EP1169349B1 Process for preparing gonadotropin compositions |
| 03/28/2007 | EP1019446B1 Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor |
| 03/28/2007 | EP1011642B1 Osmotic delivery system with semipermeable plug |
| 03/28/2007 | EP0957806B1 COMPOSITIONS TO CONTROL ORAL MICROBIAL OXIDATION-REDUCTION (E h) LEVELS |
| 03/28/2007 | CN1938079A Polymer-stabilised, crystallised, catanionic membranes, preparation method thereof and applications of same |
| 03/28/2007 | CN1938078A Process for the formation of particulate material |
| 03/28/2007 | CN1938058A Solid pharmaceutical preparation for dialysis |
| 03/28/2007 | CN1938049A Polymer particles containing active agents |